Iradimed (IRMD) Cash from Financing Activities (2013 - 2026)
Iradimed (IRMD) reported Cash from Financing Activities of -$2.6 million for Q1 2026, down 14.4% year-over-year from -$3.0 million in Q1 2025, and up 76.03% on a QoQ basis from -$10.9 million in Q4 2025.
Iradimed (IRMD) has 14 years of Cash from Financing Activities data on file, last reported at -$2.6 million in Q1 2026.
- Quarterly Cash from Financing Activities fell 14.4% year-over-year to -$2.6 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was -$17.9 million (down 109.11% YoY) and the FY2025 annual result came in at -$17.6 million, down 22.77% from the prior year.
- Cash from Financing Activities improved to -$2.6 million in Q1 2026 per IRMD's latest filing, from -$10.9 million in the prior quarter.
- Across five years, Cash from Financing Activities topped out at $52341.0 in Q3 2022 and bottomed at -$13.3 million in Q1 2023.
- The 5-year median for Cash from Financing Activities is -$2.2 million (2025), against an average of -$3.6 million.
- The widest annual swing landed in 2022, when Cash from Financing Activities tumbled 34536.13%; it then surged 71.67% in 2025.
- Tracing IRMD's Cash from Financing Activities over 5 years: stood at -$198457.0 in 2022, then sank by 32.32% to -$262590.0 in 2023, then sank by 820.64% to -$2.4 million in 2024, then tumbled by 349.78% to -$10.9 million in 2025, then surged by 76.03% to -$2.6 million in 2026.
- Per Business Quant, the three latest IRMD Cash from Financing Activities figures stand at -$2.6 million (Q1 2026), -$10.9 million (Q4 2025), and -$2.2 million (Q3 2025).
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Cash from Financing Activities (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 152.82 Bn | 146.17 Bn | 6.27 Bn | 17.31 Bn |
| 2 | Stryker | 115.07 Bn | 112.19 Bn | 3.81 Bn | -1.51 Bn |
| 3 | Medtronic | 95.25 Bn | 87.08 Bn | 5.76 Bn | -2.09 Bn |
| 4 | Boston Scientific | 71.38 Bn | 70.17 Bn | 3.61 Bn | -260.00 Mn |
| 5 | Edwards Lifesciences | 51.08 Bn | 47.41 Bn | 1.29 Bn | -451.20 Mn |
| 6 | Koninklijke Philips | 29.38 Bn | 26.07 Bn | 2.07 Bn | -26.93 Mn |
| 7 | Dexcom | 28.84 Bn | 27.72 Bn | 750.30 Mn | -25.00 Mn |
| 8 | GE HealthCare Technologies | 28.56 Bn | 26.49 Bn | 1.98 Bn | 21.00 Mn |
| 9 | Steris | 20.71 Bn | 20.30 Bn | 697.10 Mn | -97.90 Mn |
| 10 | Iradimed | 1.17 Bn | 1.11 Bn | 16.81 Mn | -2.61 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -2.61 Mn |
| Mar 31, 2026 | -2.61 Mn |
| Dec 31, 2025 | -10.87 Mn |
| Dec 31, 2025 | -10.87 Mn |
| Sep 30, 2025 | -2.19 Mn |
| Sep 30, 2025 | -2.19 Mn |
| Jun 30, 2025 | -2.26 Mn |
| Jun 30, 2025 | -2.26 Mn |
| Mar 31, 2025 | -2.28 Mn |
| Mar 31, 2025 | -2.28 Mn |
| Dec 31, 2024 | -2.42 Mn |
| Dec 31, 2024 | -2.42 Mn |
| Sep 30, 2024 | -1.92 Mn |
| Sep 30, 2024 | -1.92 Mn |
| Jun 30, 2024 | -1.96 Mn |
| Jun 30, 2024 | -1.96 Mn |
| Mar 31, 2024 | -8.04 Mn |
| Mar 31, 2024 | -8.04 Mn |
| Dec 31, 2023 | -262,590.00 |
| Dec 31, 2023 | -262,590.00 |
| Sep 30, 2023 | -31,370.00 |
| Sep 30, 2023 | -31,370.00 |
| Jun 30, 2023 | -89,768.00 |
| Jun 30, 2023 | -89,768.00 |
| Mar 31, 2023 | -13.27 Mn |
| Mar 31, 2023 | -13.27 Mn |
| Dec 31, 2022 | -198,457.00 |
| Dec 31, 2022 | -198,457.00 |
| Sep 30, 2022 | 52,341.00 |
| Sep 30, 2022 | 52,341.00 |
| Jun 30, 2022 | -5,725.00 |
| Jun 30, 2022 | -5,725.00 |
| Mar 31, 2022 | -12.55 Mn |
| Mar 31, 2022 | -12.55 Mn |
| Dec 31, 2021 | 2,157.00 |
| Dec 31, 2021 | 2,157.00 |
| Sep 30, 2021 | 54,154.00 |
| Sep 30, 2021 | 54,154.00 |
| Jun 30, 2021 | 4,361.00 |
| Jun 30, 2021 | 4,361.00 |
| Mar 31, 2021 | -36,247.00 |
| Mar 31, 2021 | -36,247.00 |
| Dec 31, 2020 | -277,492.00 |
| Dec 31, 2020 | -277,492.00 |
| Sep 30, 2020 | 868,242.00 |
| Sep 30, 2020 | 868,242.00 |
| Jun 30, 2020 | -256,575.00 |
| Jun 30, 2020 | -256,575.00 |
| Mar 31, 2020 | 188,307.00 |
| Mar 31, 2020 | 188,307.00 |
| Dec 31, 2019 | -39,955.00 |
| Dec 31, 2019 | -39,955.00 |
| Sep 30, 2019 | 1.71 Mn |
| Sep 30, 2019 | 1.71 Mn |
| Jun 30, 2019 | -82,197.00 |
| Jun 30, 2019 | -82,197.00 |
| Mar 31, 2019 | 434,232.00 |
| Mar 31, 2019 | 434,232.00 |
| Dec 31, 2018 | -288,277.00 |
| Dec 31, 2018 | -288,277.00 |
| Sep 30, 2018 | 998,667.00 |
| Sep 30, 2018 | 998,667.00 |
| Jun 30, 2018 | 127,936.00 |
| Jun 30, 2018 | 127,936.00 |
| Mar 31, 2018 | 91,548.00 |
| Mar 31, 2018 | 91,548.00 |
| Dec 31, 2017 | -86,174.00 |
| Dec 31, 2017 | -86,174.00 |
| Sep 30, 2017 | -265,665.00 |
| Sep 30, 2017 | -265,665.00 |
| Jun 30, 2017 | -1.54 Mn |
| Jun 30, 2017 | -1.54 Mn |
| Mar 31, 2017 | -10,867.00 |
| Mar 31, 2017 | -10,867.00 |
| Dec 31, 2016 | 83,240.00 |
| Dec 31, 2016 | 83,240.00 |
| Sep 30, 2016 | 411,095.00 |
| Sep 30, 2016 | 411,095.00 |
| Jun 30, 2016 | -4.24 Mn |
| Jun 30, 2016 | -4.24 Mn |
| Mar 31, 2016 | -5.38 Mn |
| Mar 31, 2016 | -5.38 Mn |
| Dec 31, 2015 | 1.13 Mn |
| Dec 31, 2015 | 1.13 Mn |
| Sep 30, 2015 | 837,653.00 |
| Sep 30, 2015 | 837,653.00 |
| Jun 30, 2015 | 57,030.00 |
| Jun 30, 2015 | 57,030.00 |
| Mar 31, 2015 | 304,270.00 |
| Mar 31, 2015 | 304,270.00 |
| Dec 31, 2014 | 270,228.00 |
| Dec 31, 2014 | 270,228.00 |
| Sep 30, 2014 | 12.65 Mn |
| Sep 30, 2014 | 12.65 Mn |
| Jun 30, 2014 | -203,225.00 |
| Jun 30, 2014 | -203,225.00 |
| Mar 31, 2014 | -6,333.00 |
| Mar 31, 2014 | -6,333.00 |
| Dec 31, 2013 | -299,130.00 |
| Dec 31, 2013 | -299,130.00 |
| Sep 30, 2013 | -211,525.00 |
| Sep 30, 2013 | -211,525.00 |